The UK Government and pharmaceutical companies have agreed a new five-year, multi-billion pricing deal that will introduce a fixed limit on NHS spend on branded medicines for the first time ever with all additional expenditure above this level paid for by industry. The breakthrough deal will allow the NHS to increase the availability and use of the best branded medicines and most innovative treatments without risking a spiralling bill for the taxpayer. At the same time, pharmaceutical companies will benefit from greater certainty on how much will be spent each year and increased use of new and recently developed medicines. This will strengthen Britain’s life science sector and its ability to compete globally.

For more details, go to: https://www.gov.uk/government/news/government-agrees-breakthrough-drug-pricing-deal-with-pharmaceutical-firms